This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: The General Hospital Corporation. Active years: 2019-2026.
Company Filing History:
Years Active: 2019-2026
Title: Florian Eichler: Innovator in Adrenomyeloneuropathy Research
Introduction
Florian Eichler is a prominent inventor based in Cambridge, MA (US), known for his significant contributions to the field of medical research, particularly in the diagnosis and treatment of adrenomyeloneuropathy (AMN). With a total of 3 patents, his work has the potential to impact the lives of many individuals affected by this condition.
Latest Patents
Eichler's latest patents include innovative methods for identifying and treating adrenomyeloneuropathy. One of his patents outlines a method for detecting AMN in human male subjects by determining the levels of specific biomarkers, such as MFGE8, C1qa, Trem2, and Gas6, in biological samples obtained from the spine. This method allows for the detection of AMN by comparing these levels to reference levels. Additionally, he has developed a treatment method that involves administering an anti-MFGE8 antibody to affected individuals. Another significant patent focuses on the intrathecal delivery of nucleic acid sequences encoding ABCD1 for the treatment of X-linked Adrenoleukodystrophy (X-ALD), which is related to AMN.
Career Highlights
Florian Eichler is affiliated with The General Hospital Corporation, where he continues to advance his research and innovation in the medical field. His work is characterized by a commitment to improving diagnostic and therapeutic approaches for complex neurological conditions.
Collaborations
Eichler collaborates with esteemed colleagues, including Yi Gong and Casey Maguire, to further enhance the impact of his research and to explore new avenues for treatment and diagnosis.
Conclusion
Florian Eichler's contributions to the field of adrenomyeloneuropathy research exemplify the importance of innovation in medicine. His patents and ongoing work hold promise for improving the lives of those affected by this condition.